p-Cresol and Cardiovascular Risk in Mild-to-Moderate Kidney DiseaseBjörn Meijers, Pieter Evenepoel, Kathleen Claes et al.|Clinical Journal of the American Society of Nephrology|2010Cited by 309
Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized studyBart Maes, Yves Vanrenterghem, Kathleen Claes et al.|Kidney International|2004Cited by 263
Intrarenal Resistive Index after Renal TransplantationMaarten Naesens, Yves Vanrenterghem, Line Heylen et al.|New England Journal of Medicine|2013Cited by 226
Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKDRuben Poesen, Björn Meijers, Kathleen Claes et al.|Journal of the American Society of Nephrology|2016Cited by 217
Diagnosis, management and treatment of the Alport syndrome – 2024 guideline on behalf of ERKNet, ERA and ESPNRoser Torrá, Beata S. Lipska‐Ziętkiewicz, Frederic Acke et al.|Nephrology Dialysis Transplantation|2024Cited by 42